| Literature DB >> 35661005 |
Kim van der Ham1, Charissa van Zwol-Janssens1, Birgitta K Velthuis2, Maria P H Koster3, Yvonne V Louwers1, Dustin Goei2, Maurits S H Blomjous4, Arie Franx3, Bart C J M Fauser5, Eric Boersma6, Joop S E Laven1, Ricardo P J Budde7.
Abstract
OBJECTIVE: To determine the prevalence of incidental findings (IFs) on coronary computed tomography (CCT) in women aged 45-55 years and previously diagnosed with reproductive disorders such as polycystic ovary syndrome (PCOS), premature ovarian insufficiency (POI) or preeclampsia (PE).Entities:
Keywords: Computed tomography; Incidental findings; Polycystic ovary syndrome; Preeclampsia; Premature ovarian insufficiency
Year: 2022 PMID: 35661005 PMCID: PMC9167323 DOI: 10.1186/s13244-022-01238-z
Source DB: PubMed Journal: Insights Imaging ISSN: 1869-4101
Fig. 1Examples of a moderate liver and a moderate lung IF in different field of views. a An example of a moderate liver IF (a hypervascular lesion) in a full field of view (FOV) with a ‘soft tissue’ window level (C:40 W:400). b The same CTA as a, but in a small FOV, in which the moderate liver IF falls beyond the area of this reconstruction. c An example of a moderate lung IF (a lung nodule) in a full FOV with a ‘lung’ window level (C:-600 W:1200). d The same CTA as c, but in the small FOV, in which the lung nodule falls beyond the area if this reconstruction
Fig. 2Flowchart methods and results. The IFs shown in this figure are IFs detected in the small FOV. *Major IFs, in the POI group it included 2 major lung IFs and in the PE group 1 major lung IF
Moderate/major incidental findings in the three different patient populations
| PCOS ( | POI ( | PE ( | Total ( | |
|---|---|---|---|---|
| Women with 1 IF | 15 (14.9) | 7 (7.2) | 23 (8.0) | 45 (9.3) |
| Women with 2 or more IFs | 1 (1.0) | 6 (6.2) | 2 (0.7) | 9 (1.9) |
| Lung | 6 (5.9) | 5 (5.2)± | 6 (2.1)† | 17 (3.5) |
| Liver | 4 (4.0) | 4 (4.1) | 7 (2.4) | 15 (3.1) |
| Lymphadenopathy | 2 (2.0) | 3 (3.1) | 2 (0.7) | 7 (1.4) |
| Breast | 1 (1.0) | – | 1 (0.3) | 2 (0.4) |
| Heart | 2 (2.0) | 5 (5.2) | 8 (2.8) | 15 (3.1) |
| Gastrointestinal tract | – | 1 (1.0) | – | 1 (0.2) |
| Blood vessels | 1 (1.0) | – | 1 (0.3) | 2 (0.4) |
| Kidney/adrenal | 1 (1.0) | – | – | 1 (0.2) |
| Mediastinum | – | – | 1 (0.3) | 1 (0.2) |
| Follow-up required | 12 (11.9) | 13 (13.4) | 23 (8.0) | 48 (9.9) |
| Follow-up performed in EMC or UMCU | 7 (58.3*) | 7 (53.8*) | 16 (69.6*) | 30 (62.5*) |
| Follow-up performed by: | ||||
| Ultrasound | 1 (16.7**) | 2 (28.6**) | 5 (31.3**) | 8 (28.6**) |
| CT scan or MRI | 5 (83.3**) | 3 (42.9**) | 6 (37.5**) | 14 (46.7**) |
| PET scan | – | – | 2 (12.5**) | 2 (7.1**) |
| X-ray | – | – | 1 (6.3**) | 1 (3.6**) |
| Consultation | 1 (14.3**) | 2 (28.6**) | 2 (12.5**) | 5 (16.7**) |
| Clinically relevant Findings a | 1 (14.3**) | 3 (42.9**) | 5 (31.3**) | 9 (32.1**) |
Values are observed data in number of women with moderate or major incidental findings (% valid). This table shows the detected IFs in the small field of view (FOV)
PCOS, polycystic ovary syndrome; POI, primary ovarian insufficiency; PE, preeclampsia; IF, Incidental finding; EMC, Erasmus Medical Center; UMCU, University Medical Center Utrecht; CT, computed tomography; MRI, magnetic resonance imaging
±The lung IFs of 2 women were classified as major
†The lung IF of one woman was classified as major
aClinically relevant findings = incidental findings which required further treatment
*Percentage of follow-up required
**Percentages of follow-up performed in EMC or UMCU
Baseline characteristics
| PCOS ( | POI ( | PE ( | |
|---|---|---|---|
| Age, median (IQR) (years) | 48.6 (46.7–53.2) | 48.2 (46.5–51.9) | 46.2 (43.7–49.3) |
| BMI, median (IQR) (kg/m2) | 27.3 (23.6–32.0) | 24.9 (22.3–27.7) | 26.5 (23.4–30.4) |
| Ethnicity (Northern-European), | 86 (86.9) | 94 (96.9) | 123 (90.4) |
| Educational level, | |||
| Low | 15 (16.0) | 18 (19.4) | 41 (15.0) |
| Middle | 41 (43.6) | 34 (36.6) | 109 (39.8) |
| High | 38 (40.4) | 41 (44.1) | 124 (45.3) |
| Ever smoker, | 39 (39.4) | 47 (49.5) | 104 (37.7) |
| Current alcohol use, | 64 (64.6) | 70 (75.3) | 192 (68.8) |
| Oral contraceptive use, | |||
| Ever | 77 (77.8) | 90 (100.0) | 242 (89.0) |
| Never | 9 (9.1) | – | 10 (3.7) |
| Now | 13 (13.1) | – | 20 (7.4) |
| Nulliparous, | 17 (20.0) | 10 (16.1) | – |
| Menopausal status, | 27 (31.0) | 97 (100.0) | 99 (40.1) |
| HRT use, | |||
| Ever | 8 (27.6) | 59 (67.0) | 4 (4.9) |
| Never | 21 (72.4) | 27 (30.7) | 73 (89.0) |
| Now | – | 2 (2.3) | 5 (6.1) |
| Relevant coronary artery diseasea | 5 (5.4) | 3 (3.1) | 18 (6.7) |
| Women with IF(s) | 32 (31.7) | 22 (22.7) | 42 (14.6) |
Values are observed data and represent medians (IQR) or number of patients (valid %). The presented data of IFs are minor, moderate and major IFs, all detected in the small field of view
IQR, interquartile range; PCOS, polycystic ovary syndrome; POI, primary ovarian insufficiency; PE, preeclampsia; BMI, body mass index; HRT, hormone replacement therapy; IF, incidental finding. aRelevant coronary artery disease = luminal stenosis of ≥ 50% or a CAC score ≥ 100 AU
Comparison of incidental findings on full field of view (FOV) versus small FOV
| Full FOV-EMC ( | Small FOV-EMC ( | |
|---|---|---|
| Women with IFs | 78 (100.0) | 60 (76.9) |
| Women with 1 IF | 57 (73.1) | 49 (62.8) |
| Women with 2 or more IFs | 21 (26.9) | 11 (14.1) |
| Number of IFs | 101 (100.0) | 72 (71.3*) |
| Minor IFs | 40 (39.6) | 33 (82.5*) |
| Moderate IFs | 61 (60.4) | 39 (63.91) |
| Major IFs | – | – |
| Follow-up requireda | 46 (59.0) | 30 (38.5) |
| Clinically relevant Findingsb | 7 (15.2**) | 6 (20.0**) |
The 78 CCTs of women with a detected incidental finding (IF) on full field of view (FOV) in the Erasmus Medical Center (EMC) were analyzed again in the small FOV (180 mm) reconstruction. Values are observed data in numbers (%)
aFollow-up required = the number of women for whom follow-up of the incidental finding was required
bClinically relevant findings = incidental findings which required further treatment
*Percentage of number IFs in small FOV compared to full FOV
**Percentage of follow-up required